Nebenwirkungen · Trulicity
Trulicity 0.75 mg solution for injection in pre-filled pen Trulicity 1.5 mg solution for injection in pre-filled pen Trulicity 3 mg solution for injection in pre-filled pen Trulicity 4.5 mg solution for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 9
HOS-130067 · Präparat HOS-096833
Hypoglycaemia When dulaglutide 0.75 mg and 1.5 mg were used as monotherapy or in combination with metformin alone or metformin and pioglitazone, the incidences of documented symptomatic hypoglycaemia were 5.9 % to 10.9 % and the rates were 0.14 to 0.62 events/patient/year, and no episodes of severe hypoglycaemia were reported.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-30T14:51:00Z · SHA-256 8f7c34e4753bded4db7c0494f49b503f91f5736e3b7e360143648c1ad38b32e3 · Passage dabca590a31d0a90e290149c35a28bcee8ba9e5b29af41875ee0a927f02b994e · Zeichen 4459–4787 im Abschnitt